Merit Medical Systems | MMSI



Peers Price Chg Day Year Date
Terumo 2,665.00 -61.50 -2.26% -1.66% May/15
Olympus 1,914.00 -22.50 -1.16% -22.68% May/15
Abbott 128.51 -0.61 -0.47% 22.76% May/14
AtriCure 32.25 0.77 2.45% 45.80% May/14
Baxter International 30.29 -0.89 -2.84% -14.08% May/14
Becton, Dickinson and Co. 170.93 -4.46 -2.54% -28.01% May/14
Boston Scientific 102.82 -0.26 -0.25% 39.71% May/14
Cooper Companies 80.46 -1.39 -1.70% -16.18% May/14
Dexcom 86.48 2.28 2.71% -31.35% May/14
Edwards Lifesciences 76.66 1.26 1.67% -15.04% May/14
Globus Medical 58.17 -0.08 -0.14% -9.86% May/14
Haemonetics 68.65 -0.49 -0.71% -28.85% May/14
Hologic 55.35 -1.77 -3.10% -26.08% May/14
Integra LifeSciences 12.92 -0.59 -4.37% -51.19% May/14
ICU Medical 135.93 -7.66 -5.33% 30.10% May/14
J&J 146.32 -2.26 -1.52% -4.25% May/14
Medtronic 84.25 -0.87 -1.02% -0.72% May/14
3M 147.94 -2.99 -1.98% 46.26% May/14
Merit Medical Systems 97.00 -0.61 -0.62% 15.82% May/14
Pfizer 21.99 -0.91 -3.97% -23.73% May/14
Insulet 321.46 7.00 2.23% 77.87% May/14
STAAR Surgical 17.43 -1.57 -8.26% -59.60% May/14
Stryker 386.20 -1.76 -0.45% 16.48% May/14
Teleflex 125.33 -1.68 -1.32% -41.06% May/14
Tandem Diabetes Care 22.86 -0.27 -1.17% -51.74% May/14
Zimmer Biomet Holdings 97.49 0.05 0.05% -18.71% May/14

Indexes Price Day Year Date
USND 19147 136.72 0.72% 14.36% May/14
US2000 2083 -19.24 -0.92% -1.25% May/14

Merit Medical Systems traded at $97.00 this Wednesday May 14th, decreasing $0.61 or 0.62 percent since the previous trading session. Looking back, over the last four weeks, Merit Medical Systems lost 5.48 percent. Over the last 12 months, its price rose by 15.82 percent. Looking ahead, we forecast Merit Medical Systems to be priced at 94.09 by the end of this quarter and at 89.04 in one year, according to Trading Economics global macro models projections and analysts expectations.

Merit Medical Systems, Inc. designs, develops, manufactures and markets medical products for interventional and diagnostic procedures. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.